1. Recent Funding
2. Investors
3. Leerink Partners

Leerink Partners has backed 1 company on Recent Funding, 0 in the last 12 months; its most recent deal is Parabilis Medicines (2018-05-16).

What Leerink Partners invests in

• Health and bio · 1 · 100%

How Leerink Partners invests

Share is of the 1 round on Recent Funding that name Leerink Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with Leerink Partners	Total raised	Latest raise
PParabilis Medicines Health and bio	May 16, 2018 Series b+ · $66M	$801M	Jan 8, 2026 Series b+

Most frequent co-investors

• GGV1 shared round · last May 16, 2018
• 66 Dimensions Capital1 shared round · last May 16, 2018
• BBlue Pool Capital1 shared round · last May 16, 2018
• HHorizons Ventures1 shared round · last May 16, 2018
• NNan Fung Group1 shared round · last May 16, 2018
• DDeerfield Management1 shared round · last May 16, 2018
• BBoyu Capital1 shared round · last May 16, 2018
• WWuXi AppTec Corporate Ventures1 shared round · last May 16, 2018

Portfolio companies are the companies on Recent Funding with a round that lists Leerink Partners, which is a subset of its real portfolio. API: /api/v1/investors/leerink-partners. All investors.